IndoUSrare Announces Pitch4RARE 2025 Winners Advancing Rare Disease Innovation

IndoUSrare announced GenoPhe Biotech Pvt Ltd and IUVA Labs as the winners of Pitch4RARE 2025, its virtual startup pitch competition held on December 9. Attox Research Laboratories received special recognition. Pitch4RARE aims to identify and advance patient-centered, innovative solutions for equitable care for individuals with rare diseases globally. An eminent panel of industry, technology, and healthcare leaders judged the competition, highlighting crucial advancements in rare disease innovation.

IndoUSrare, the Indo US Organization for Rare Diseases, has officially announced the winners of its Pitch4RARE 2025 startup pitch competition, recognizing significant advancements in rare disease innovation. GenoPhe Biotech Pvt Ltd and IUVA Labs were named the top winners, with Attox Research Laboratories receiving a special recognition for their contributions. The virtual competition, held on December 9, serves as a crucial platform to identify and promote innovative, patient-centered solutions aimed at advancing equitable care for individuals living with rare diseases worldwide. This initiative is vital for creating global pathways to better care and improved outcomes for patients.The Pitch4RARE 2025 event featured a distinguished judging panel comprising leaders from various sectors, including industry, technology, and healthcare. The panel included Abhishek Mathur, PhD, MBA; Chidiebube C.; Christiaan Engstrom; Mahesh Narayanan, MS; and Mandeep Kaur, MD, MS. Their collective expertise was instrumental in evaluating and selecting groundbreaking ideas poised to drive the future of rare disease care. By fostering such competitions, IndoUSrare continues its mission to support and elevate organizations developing much-needed innovations in this critical medical area. The announcement underscores the ongoing commitment to addressing the complex challenges faced by the rare disease community through collaborative and inventive approaches, ultimately aiming to improve the quality of life for affected individuals.